Methods and kits for detection of cryptosporidium parvum

Details Methods and kits for detection of cryptosporidium parvum Methods and kits for detection of cryptosporidium parvum

2000-07-18

2002-05-28

Siew, Jeffrey (Department: 1656)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Preparing compound containing saccharide radical

C435S006120, C435S091100, C536S022100, C536S023100, C536S024100, C536S024200, C536S024300, C536S024330

Reexamination Certificate

active

06395517

ABSTRACT:

BACKGROUND OF THE INVENTION
Cryptosporidium parvum
(phylum Apicomplexa) is a coccidian protozoan capable of parasitizing the intestinal tract of a variety of mammalian species. The protozoan is generally believed to be spread by an oral-fecal route, infecting the intestinal epithelia and, to a lesser extent, the extraintestinal epithelia causing severe diarrhea.
C. parvum
has been increasingly recognized as the causative agent of recent waterborne outbreaks of gastroenteritis.
Although usually self-limiting, the diarrheal disease can be prolonged and life threatening to the young and to the immunosuppressed. While first recognized as a veterinary pathogen, cryptosporidiosis has gained in importance with the spread of AIDS-related immunosuppression. Further, numerous outbreaks of cryptosporidiosis have been reported in the United States involving children attending day-care facilities (Jenkins et al., 1997, U.S. Pat. No. 5,591,434, which is incorporated by reference herein as if set forth in its entirety). The disease has also been implicated as having a significant role in the vicious cycle of malnutrition/diarrhea among children in developing countries.
In a recent study, the 50% infectious dose in normal immunocompetent individuals was determined to be 132 oocysts and as few as 30 oocysts caused infection (Dupont et al., 1995, N. Eng. J. Med. 332:855-859). At present, there does not appear to be any prophylactic therapy available to prevent this parasitic disease in humans or in animals (Jenkins et al., supra), and there is no effective chemotherapeutic treatment for cryptosporidiosis once the host has been infected.
Cryptosporidium parvum
exists in nature in the form of environmentally resistant, thick-walled oocysts. The oocysts are known to remain viable for extended periods of time and are resistant to conventional water disinfection methods. Due to massive shedding of oocysts in the feces of infected animals or individuals and the robust nature of the oocysts, they are frequently present in raw surface water (LeChevallier et al., 1991, Appl. Environ. Microbiol. 56:1423-1428) and finished drinking water (LeChevallier and Norton, 1995, J. Am. Water Works Assoc. 87:54-68). Currently, the U.S. Environmental Protection Agency Information Collection Rule (ICR) mandates the use of the indirect fluorescent antibody (IFA) method for the detection of Cryptosporidium oocysts in water concentrates (U.S. Environmental Protection Agency, 1996, Fed. Regist. 61:24354-24388). While the IFA method does not distinguish between viable and nonviable oocysts, the use of fluorogenic vital dyes may distinguish between viable and nonviable oocysts (Campbell et al., 1992, Appl. Environ. Microbiol. 58:3488-3493). However, the use of these microscopic techniques is hampered by their labor-intensive, time-consuming nature, their inability to distinguish between human pathogenic
C. parvum
oocyst and the oocyst of animal pathogenic Cryptosporidium species, and the inability of the tests to differentiate infectious and non-infectious oocysts.
Oocyst resistance to chlorination, difficulties in effective methods for detection of the parasite, and a lack of effective treatment for cryptosporidiosis have contributed to the spread of the organism. Accordingly, the importance of prophylaxis by detection of the parasite in drinking water before it is ingested by the human host has given impetus to the development of methods for the effective detection of
C. parvum
in water samples.
Recently, various strategies have been combined with standard polymerase chain reaction assay (PCR) to detect the presence of viable
C. parvum
oocysts, including integration of in vivo excystation (Deng et al., 1997, Appl. Environ. Microbiol. 63:3134-3138; Filkhorn et al., 1994, Zentralbl. Hyg. Unweltmed. 195:489-494; Wagner-Weining and Kimmig, 1995, Appl. Environ. Microbiol. 61:4514-4516), and the use of reverse-transcriptase PCR (RT-PCR) for the detection of mRNA transcripts found only in viable oocysts (Rochelle et al., 1997, Appl. Environ. Microbiol. 63:2029-2037; Stinear et al., 1996, Appl. Environ. Microbiol. 62:3385-3390). Further, infectivity assessment by integrated cell culture-PCR (CC-PCR) has also been developed (Di Giovanni et al., 1997, Proceedings of the American Water Works Assoc., Water Quality Tech. Conf., Denver, CO; De Leon and Rochelle., 1998, U.S. Pat. No. 5,770,368; Rochelle et al., 1997, Appl. Environ. Microbiol. 63:2029-2037). However, although these prior art methods provide high specificity and sensitivity, they do not provide a quantitative measure of starting target nucleic acid copy numbers and, therefore, the prior art methods do not accurately measure the numbers of oocysts in the samples. Further, until the present invention, there is no report that CC-PCR has been successfully used to detect infectious
C. parvum
in environmental raw water samples.
Although there has been limited success in detection of oocysts in environmental raw water samples using PCR methods, CC-PCR detection of infectious
C. parvum
oocysts in environmental raw water samples has been hampered by, among other things, difficulties in: removing inhibitors of PCR, quantitation of organisms, ensuring that sufficient equivalent volume is assayed, removal of compounds cytotoxic to the cell culture, and ensuring that the process of collection and analysis does not inactivate the oocysts. Nonetheless, the detection of infectious
C. parvum
oocyst contamination in environmental raw water samples is important in raw-source water assessment for effective watershed management and also in enabling the evaluation of the efficiency and quality of drinking water treatment procedures. Therefore, while the methods of present invention can be used to detect infectious oocysts in finished drinking water to protect the public health, the procedures disclosed herein also permit the examination of, inter alia, raw water, process water, and waste streams which is of great value for understanding parasite occurrence and the efficacy of water treatment processes.
Further, the prior art PCR-based assays for
C. parvum
require confirmation that the parasite is infectious and/or that the DNA amplified is, indeed, the
C. parvum
-specific target sequence by complex methodologies requiring, inter alia, skilled persons trained in recombinant DNA techniques. For example, heat shocking the organisms followed by reverse transcriptase PCR (RT-PCR) has been used to detect viable organisms (De Leon and Rochelle, 1998, U.S. Pat. No. 5,770,368) (hereinafter the '368 patent). That patent also teaches the alternative procedure of inoculating susceptible mammalian cells with a sample in order to detect infectious
C. parvum
by RT-PGR.
In either case, all PCR-based prior art methods require that the PCR amplification products be examined using recombinant DNA techniques to confirm that the
C. parvum
target nucleic acid sequence has, indeed, been specifically amplified. Typically, PCR amplification products are separated according to size on agarose gels and then the fragments are visualized by ethidium bromide-fluorescence staining under ultraviolet light to determine the presence of the appropriately-sized fragment as predicted by the primer pair used to amplify the target nucleic acid sequence. The actual sequence identity of the putative PCR fragment may be confirmed by Southern blot hybridization using a short internal DNA probe which complements the DNA expected in the PCR product and which is labeled so that it may be detected on the blot. Thus, when the target PCR product has been generated by the amplification reaction, the matching labeled probe will hybridize to it thereby confirming the product's identity. Alternatively, the putative PCR product may be cloned and sequenced by standard methods. Thus, the prior art methods require complex, time-consuming sample handling by a technician skilled in recombinant DNA methodology.
Moreover, none of the prior art PCR-based methods are quantitative and, therefore, those methods do not provi

Affiliated with

Also associated with

Rating

Methods and kits for detection of cryptosporidium parvum does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and kits for detection of cryptosporidium parvum, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and kits for detection of cryptosporidium parvum will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2877771